Current Report Filing (8-k)
08 July 2021 - 7:21AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
July 7, 2021
Date of Report (Date of earliest event reported)
_________________
OpGen, Inc.
(Exact name of registrant as specified in its charter)
_________________
Delaware
(State or other jurisdiction of incorporation or
organization)
|
|
001-37367
(Commission
File Number)
|
|
06-1614015
(I.R.S. Employer
Identification No.)
|
9717 Key West Avenue, Suite 100
Rockville, MD 20850
(Address of principal executive offices, including zip code)
(240) 813-1260
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
_________________
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[_] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered
pursuant to Section 12(b) of the Act:
|
Title
of Each Class
|
Trading
Symbol
|
Name of
Each Exchange on Which Registered
|
Common Stock
|
OPGN
|
Nasdaq Capital Market
|
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company [_]
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]
Item 8.01 — Other Events.
On July 7, 2021, OpGen, Inc. (the “Company”) issued a press
release announcing the continued adjournment of its 2021 annual meeting of stockholders solely with respect to proposal 2 relating to
the approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to increase the authorized
number of shares of capital stock from 60,000,000 to 110,000,000 shares and authorized number of shares of common stock from 50,000,000
to 100,000,000 shares. The Annual Meeting will reconvene at 10:00 a.m. Eastern Time on August 5, 2021, at the offices of the Company located
at 9717 Key West Ave, Suite 100, Rockville, MD 20850. A copy of such press release is attached to this Current Report on Form 8-K as Exhibit
99.1.
Item 9.01 — Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are filed herewith:
99.1 Press release, dated July 7, 2021.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
OpGen, Inc.
|
|
|
By:
|
|
/s/ Timothy C. Dec
|
|
|
Name:
|
|
Timothy C. Dec
|
|
|
Title:
|
|
Chief Financial Officer
|
Date: July 7, 2021
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2024 to Oct 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Oct 2023 to Oct 2024